Skip to results
Modify your search
NARROW
1-4 of 4
Authors: Stefan D Anker
Journal Article
Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone—a FIDELITY analysis
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 10–19, https://doi.org/10.1093/ehjcvp/pvae074
Published: 08 October 2024
Journal Article
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 2, March 2023, Pages 183–191, https://doi.org/10.1093/ehjcvp/pvad001
Published: 13 January 2023
Journal Article
Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 1, January 2023, Pages 85–93, https://doi.org/10.1093/ehjcvp/pvac054
Published: 17 October 2022
Journal Article
EDITOR'S CHOICE
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 3, July 2018, Pages 180–188, https://doi.org/10.1093/ehjcvp/pvy015
Published: 03 May 2018
